Human T-Cell Leukemia Virus in Lymphocytes of Two Hemophiliacs with the Acquired Immunodeficiency Syndrome

  1. ERSKINE L. PALMER, Ph.D.;
  2. ROSEMARY B. RAMSEY, M.S.;
  3. PAUL F. FEORINO, Ph.D.;
  4. ALYNE K. HARRISON, B.S.;
  5. CIRILO CABRADILLA, Ph.D.;
  6. DONALD P. FRANCIS, M.D., D.Sc.;
  7. MAN-CHIU POON, M.D.; and
  8. BRUCE L. EVATT, M.D.
  1. Atlanta, Georgia; and Calgary, Alberta
    , Canada

    Abstract

    Fresh and cultured peripheral blood cells from two patients with hemophilia A and the acquired immunodeficiency syndrome were examined for markers of infection with human T-cell leukemia virus (HTLV) type I. Neither patient had antibody to membrane antigens of HTLV-infected cells at the time of culture. Electron microscopy of peripheral blood cells from Patient 1 and cultured cells from Patient 2 showed type C retrovirus-like particles. Examination of peripheral blood lymphocytes showed other smaller virus-like particles in circulating mononuclear cells from both patients. Indirect immunofluorescence of peripheral mononuclear cells from both patients and of cultured cells from Patient 2 showed staining with antibodies to purified HTLV and to HTLV core proteins p24 and p19.

    Article and Author Information

    • ▸From the Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia; and the Division of Hematology/Oncology, University of Calgary and Foothills Hospital, Calgary, Alberta, Canada.

    • ▸Requests for reprints should be addressed to Erskine L. Palmer, Ph.D.; Division of Viral Diseases, Centers for Disease Control, 1600 Clifton Road, Building 7, Room SB40; Atlanta, GA 30333.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement